Epistasis between serine protease inhibitor Kazal-type 5 (SPINK5) and thymic stromal lymphopoietin (TSLP) genes contributes to childhood asthma

Journal of Allergy and Clinical Immunology

Volumn 134, Issue 4, 2014, Pages 891-899.e3

  Biagini Myers, Jocelyn M ^a   Martin, Lisa J ^a   Kovacic, Melinda Butsch ^a   Mersha, Tesfaye B ^a   He, Hua ^a   Pilipenko, Valentina ^a   Lindsey, Mark A ^a   Ericksen, Mark B ^a   Bernstein, David I ^a   Lemasters, Grace K ^a   Lockey, James E ^a   Khurana Hershey, Gurjit K ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Childhood asthma; epistasis; genetic association; skin related genes

Indexed keywords

FILAGGRIN; SERINE PROTEASE INHIBITOR KAZAL TYPE 5; SERINE PROTEINASE; THYMIC STROMAL LYMPHOPOIETIN; UNCLASSIFIED DRUG; CYTOKINE; INTERMEDIATE FILAMENT PROTEIN; LEUKOCYTE ELASTASE INHIBITOR; SPINK5 PROTEIN, HUMAN;

ADOLESCENT; ALLELE; ALLERGIC RHINITIS; ARTICLE; ASTHMA; BLACK PERSON; CAUCASIAN; CHILD; CONTROLLED STUDY; DEMOGRAPHY; EPISTASIS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; PHENOTYPE; QUESTIONNAIRE; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MALE; PRESCHOOL CHILD;

ADOLESCENT; AFRICAN CONTINENTAL ANCESTRY GROUP; ASTHMA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYTOKINES; EPISTASIS, GENETIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MALE; POLYMORPHISM, GENETIC; PROTEINASE INHIBITORY PROTEINS, SECRETORY;

EID: 84908145803     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2014.03.037     Document Type: Article

References (64)

1. B. Bloom, R. Cohen, and G. Freeman Summary health statistics for U.S. children: National Health Interview Survey, 2011 Vital Health Stat 10 254 2012 10
2. D.L. Duffy, N.G. Martin, D. Battistutta, J.L. Hopper, and J.D. Mathews Genetics of asthma and hay fever in Australian twins Am Rev Respir Dis 142 1990 1351 1358
3. J.R. Harris, P. Magnus, S.O. Samuelsen, and K. Tambs No evidence for effects of family environment on asthma. A retrospective study of Norwegian twins Am J Respir Crit Care Med 156 1997 43 49
4. G.H. Koppelman, H. Los, and D.S. Postma Genetic and environment in asthma: the answer of twin studies Eur Respir J 13 1999 2 4
5. M.M. Nieminen, J. Kaprio, and M. Koskenvuo A population-based study of bronchial asthma in adult twin pairs Chest 100 1991 70 75
6. M.E. March, P.M. Sleiman, and H. Hakonarson The genetics of asthma and allergic disorders Discov Med 11 2011 35 45
7. T.A. Manolio, F.S. Collins, N.J. Cox, D.B. Goldstein, L.A. Hindorff, and D.J. Hunter Finding the missing heritability of complex diseases Nature 461 2009 747 753
8. O. Zuk, E. Hechter, S.R. Sunyaev, and E.S. Lander The mystery of missing heritability: genetic interactions create phantom heritability Proc Natl Acad Sci U S A 109 2012 1193 1198
9. S.T. Weiss, B.A. Raby, and A. Rogers Asthma genetics and genomics 2009 Curr Opin Genet Dev 19 2009 279 282
10. C.N. Palmer, A.D. Irvine, A. Terron-Kwiatkowski, Y. Zhao, H. Liao, and S.P. Lee Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis Nat Genet 38 2006 441 446
11. J. Henderson, K. Northstone, S.P. Lee, H. Liao, Y. Zhao, and M. Pembrey The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study J Allergy Clin Immunol 121 2008 872 877.e9
12. I. Marenholz, R. Nickel, F. Ruschendorf, F. Schulz, J. Esparza-Gordillo, and T. Kerscher Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march J Allergy Clin Immunol 118 2006 866 871
13. N. Morar, W.O. Cookson, J.I. Harper, and M.F. Moffatt Filaggrin mutations in children with severe atopic dermatitis J Invest Dermatol 127 2007 1667 1672
14. C.N. Palmer, T. Ismail, S.P. Lee, A. Terron-Kwiatkowski, Y. Zhao, and H. Liao Filaggrin null mutations are associated with increased asthma severity in children and young adults J Allergy Clin Immunol 120 2007 64 68
15. J. Poninska, B. Samolinski, A. Tomaszewska, F. Raciborski, P. Samel-Kowalik, and A. Walkiewicz Filaggrin gene defects are independent risk factors for atopic asthma in a Polish population: a study in ECAP cohort PLoS One 6 2011 e16933
16. A.J. Rogers, J.C. Celedon, J.A. Lasky-Su, S.T. Weiss, and B.A. Raby Filaggrin mutations confer susceptibility to atopic dermatitis but not to asthma J Allergy Clin Immunol 120 2007 1332 1337
17. S. Weidinger, M. O'Sullivan, T. Illig, H. Baurecht, M. Depner, and E. Rodriguez Filaggrin mutations, atopic eczema, hay fever, and asthma in children J Allergy Clin Immunol 121 2008 1203 1209.e1
18. C. Ober, and T.C. Yao The genetics of asthma and allergic disease: a 21st century perspective Immunol Rev 242 2011 10 30
19. S. Demehri, M. Morimoto, M.J. Holtzman, and R. Kopan Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma PLoS Biol 7 2009 e1000067
20. S.F. Ziegler Thymic stromal lymphopoietin and allergic disease J Allergy Clin Immunol 130 2012 845 852
21. A. Hovnanian Netherton syndrome: skin inflammation and allergy by loss of protease inhibition Cell Tissue Res 351 2013 289 300
22. J. Genuneit, J.L. Cantelmo, G. Weinmayr, G.W. Wong, P.J. Cooper, and M.A. Riikjarv A multi-centre study of candidate genes for wheeze and allergy: the International Study of Asthma and Allergies in Childhood Phase 2 Clin Exp Allergy 39 2009 1875 1888
23. M. Kabesch, D. Carr, S.K. Weiland, and E. von Mutius Association between polymorphisms in serine protease inhibitor, Kazal type 5 and asthma phenotypes in a large German population sample Clin Exp Allergy 34 2004 340 345
24. Q. Liu, Y. Xia, W. Zhang, J. Li, P. Wang, and H. Li A functional polymorphism in the SPINK5 gene is associated with asthma in a Chinese Han Population BMC Med Genet 10 2009 59
25. A.J. Walley, S. Chavanas, M.F. Moffatt, R.M. Esnouf, B. Ubhi, and R. Lawrence Gene polymorphism in Netherton and common atopic disease Nat Genet 29 2001 175 178
26. M.B. Kovacic, J.M. Myers, N. Wang, L.J. Martin, M. Lindsey, and M.B. Ericksen Identification of KIF3A as a novel candidate gene for childhood asthma using RNA expression and population allelic frequencies differences PLoS One 6 2011 e23714
27. M. Butsch Kovacic, J.M. Biagini Myers, M. Lindsey, T. Patterson, S. Sauter, and M.B. Ericksen The Greater Cincinnati Pediatric Clinic Repository: a novel framework for childhood asthma and allergy research Pediatr Allergy Immunol Pulmonol 25 2012 104 113
28. M. Butsch Kovacic, J.M. Biagini Myers, N. Wang, L.J. Martin, M. Lindsey, and M.B. Ericksen A novel selection approach identifies six candidate epithelial genes for childhood asthma including KIF3A PLoS One 6 2011 e23714
29. L.J. Martin, J. Gupta, S.S. Jyothula, M. Butsch Kovacic, J.M. Biagini Myers, and T.L. Patterson Functional variant in the autophagy-related 5 gene promotor is associated with childhood asthma PLoS One 7 2012 e33454
30. American Thoracic Society. Standardization of Spirometry Am J Respir Crit Care Med 152 1994 1107 1136
31. The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Childhood Asthma Management Program Research Group Control Clin Trials 20 1999 91 120
32. T.W. Guilbert, W.J. Morgan, M. Krawiec, R.F. Lemanske Jr., C. Sorkness, and S.J. Szefler The Prevention of Early Asthma in Kids study: design, rationale and methods for the Childhood Asthma Research and Education network Control Clin Trials 25 2004 286 310
33. G.K. LeMasters, K. Wilson, L. Levin, J. Biagini, P. Ryan, and J.E. Lockey High prevalence of aeroallergen sensitization among infants of atopic parents J Pediatr 149 2006 505 511
34. T.M. Baye, M. Butsch Kovacic, J.M. Biagini Myers, L.J. Martin, M. Lindsey, and T.P. Patterson Differences in candidate gene association between European ancestry and African American asthmatic children PLoS One 6 2011 e16522
35. L. Asmussen, L.M. Olson, E.N. Grant, J. Fagan, and K.B. Weiss Reliability and validity of the Children's Health Survey for Asthma Pediatrics 104 1999 e71
36. H. Enomoto, K. Hirata, K. Otsuka, T. Kawai, T. Takahashi, and T. Hirota Filaggrin null mutations are associated with atopic dermatitis and elevated levels of IgE in the Japanese population: a family and case-control study J Hum Genet 53 2008 615 621
37. T.G. Epstein, G.K. LeMasters, D.I. Bernstein, M.B. Ericksen, L.J. Martin, and P.H. Ryan Genetic variation in small proline rich protein 2B as a predictor for asthma among children with eczema Ann Allergy Asthma Immunol 108 2012 145 150
38. C.R. Narayanaswamy, and D. Raghavarao Principal component analysis of large dispersion matrices Appl Stat 40 1991 309 316
39. A.L. Price, N.J. Patterson, R.M. Plenge, M.E. Weinblatt, N.A. Shadick, and D. Reich Principal components analysis corrects for stratification in genome-wide association studies Nat Genet 38 2006 904 909
40. R. Kosoy, R. Nassir, C. Tian, P.A. White, L.M. Butler, and G. Silva Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America Hum Mutat 30 2009 69 78
41. S. Purcell, B. Neale, K. Todd-Brown, L. Thomas, M.A. Ferreira, and D. Bender PLINK: a tool set for whole-genome association and population-based linkage analyses Am J Hum Genet 81 2007 559 575
42. R.S. Spielman, and W.J. Ewens The TDT and other family-based tests for linkage disequilibrium and association Am J Hum Genet 59 1996 983 989
43. P.F. Sullivan Spurious genetic associations Biol Psychiatry 61 2007 1121 1126
44. P. Descargues, C. Deraison, C. Bonnart, M. Kreft, M. Kishibe, and A. Ishida-Yamamoto Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity Nat Genet 37 2005 56 65
45. D.R. Hewett, A.L. Simons, N.E. Mangan, H.E. Jolin, S.M. Green, and P.G. Fallon Lethal, neonatal ichthyosis with increased proteolytic processing of filaggrin in a mouse model of Netherton syndrome Hum Mol Genet 14 2005 335 346
46. J.I. Sakabe, M. Yamamoto, S. Hirakawa, A. Motoyama, I. Ohta, and K. Tatsuno Kallikrein-related peptidase 5 functions in proteolytic processing of profilaggrin in cultured human keratinocytes J Biol Chem 288 2013 17179 17189
47. A. Sandilands, C. Sutherland, A.D. Irvine, and W.H. McLean Filaggrin in the frontline: role in skin barrier function and disease J Cell Sci 122 2009 1285 1294
48. S. Weidinger, H. Baurecht, S. Wagenpfeil, J. Henderson, N. Novak, and A. Sandilands Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk J Allergy Clin Immunol 122 2008 560 568.e4
49. M. Harada, T. Hirota, A.I. Jodo, Y. Hitomi, M. Sakashita, and T. Tsunoda Thymic stromal lymphopoietin gene promoter polymorphisms are associated with susceptibility to bronchial asthma Am J Respir Cell Mol Biol 44 2011 787 793
50. D.G. Torgerson, E.J. Ampleford, G.Y. Chiu, W.J. Gauderman, C.R. Gignoux, and P.E. Graves Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations Nat Genet 43 2011 887 892
51. N. Acevedo, A. Saaf, C. Soderhall, E. Melen, J. Mandelin, and C.O. Pietras Interaction between retinoid acid receptor-related orphan receptor alpha (RORA) and neuropeptide S receptor 1 (NPSR1) in Asthma PLoS One 8 2013 e60111
52. C. Orsmark-Pietras, E. Melen, J. Vendelin, S. Bruce, A. Laitinen, and L.A. Laitinen Biological and genetic interaction between tenascin C and neuropeptide S receptor 1 in allergic diseases Hum Mol Genet 17 2008 1673 1682
53. M.A. Ferreira, Z.Z. Zhao, S.F. Thomsen, M. James, D.M. Evans, and P.E. Postmus Association and interaction analyses of eight genes under asthma linkage peaks Allergy 64 2009 1623 1628
54. I. Ungvari, G. Hullam, P. Antal, P.S. Kiszel, A. Gezsi, and E. Hadadi Evaluation of a partial genome screening of two asthma susceptibility regions using Bayesian network based Bayesian multilevel analysis of relevance PLoS One 7 2012 e33573
55. B. Han, X.W. Chen, and Z. Talebizadeh FEPI-MB: identifying SNPs-disease association using a Markov Blanket-based approach BMC Bioinformatics 12 Suppl 12 2011 S3
56. B. Zhou, M.R. Comeau, T. De Smedt, H.D. Liggitt, M.E. Dahl, and D.B. Lewis Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice Nat Immunol 6 2005 1047 1053
57. Z.G. Chen, T.T. Zhang, H.T. Li, F.H. Chen, X.L. Zou, and J.Z. Ji Neutralization of TSLP inhibits airway remodeling in a murine model of allergic asthma induced by chronic exposure to house dust mite PLoS One 8 2013 e51268
58. L. Shi, S.W. Leu, F. Xu, X. Zhou, H. Yin, and L. Cai Local blockade of TSLP receptor alleviated allergic disease by regulating airway dendritic cells Clin Immunol 129 2008 202 210
59. E. Birben, C. Sackesen, N. Turgutoglu, and O. Kalayci The role of SPINK5 in asthma related physiological events in the airway epithelium Respir Med 106 2012 349 355
60. A. Briot, C. Deraison, M. Lacroix, C. Bonnart, A. Robin, and C. Besson Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome J Exp Med 206 2009 1135 1147
61. E. Rodriguez, H. Baurecht, E. Herberich, S. Wagenpfeil, S.J. Brown, and H.J. Cordell Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease J Allergy Clin Immunol 123 2009 1361 1370.e7
62. A randomized, double-blind, placebo-controlled, ascending multiple dose study to evaluate the safety, tolerability and pharmacokinetics of AMG 157 in healthy subjects. Available at: http://clinicaltrials.gov/ct2/show/NCT00972179?term=amg157&rank=1.
63. A randomized, double-blind, placebo-controlled, ascending single dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of AMG 157 in healthy subjects and subjects with moderate to severe atopic dermatitis. Bethesda (MD): U.S. National Library of Medicine (US), National Institutes of Health (NCT00757042).
64. A randomized, double-blind, placebo-controlled, parallel design, multiple-dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of AMG 157 in subjects with mild atopic asthma. Bethesda (MD): U.S. National Library of Medicine (US), National Institutes of Health (NCT01405963).